Apr 29, 2025 02:40AM TD Cowen Downgrades Spring Works Therapeutics (SWTX) to Hold

Apr 28, 2025 06:29PM SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating SpringWorks Therapeutics, Inc. Buyout

Apr 28, 2025 09:29AM Barclays Downgrades Spring Works Therapeutics (SWTX) to Equalweight

Apr 28, 2025 07:37AM H.C. Wainwright Reiterates Buy Rating on Spring Works Therapeutics (SWTX)

Apr 28, 2025 05:45AM SpringWorks Therapeutics Inc. (SWTX) options active on 61K contracts

Apr 28, 2025 02:07AM Merck Kgaa To Buy Springworks For $47 Per Share In Cash- Bloomberg

Apr 25, 2025 06:11AM SpringWorks Therapeutics Inc. (SWTX) call put ratio 2.2 calls to 1 amid wide price movement

Apr 24, 2025 04:49PM Merck confirms late-stage discussions with SpringWorks Therapeutics (SWTX) on potential acquisition

Apr 24, 2025 03:32PM SpringWorks Therapeutics springs higher as Merck KGaA takeover said close

Apr 24, 2025 03:07PM Merck KGaA Expected to Pay Close to $47 a Share for SpringWorks Therapeutics Inc. (SWTX) - WSJ

Apr 22, 2025 10:52AM Barclays on Spring Works Therapeutics (SWTX): 'April CHMP Agenda Out; Ogsiveo Meeting Today 4/22; Could De-Risk Potential M&A'

Apr 22, 2025 10:49AM SpringWorks Therapeutics Inc. (SWTX) gains on renewed chatter

Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma

Mar 6, 2025 10:04AM SpringWorks Therapeutics Inc. (SWTX) call put ratio 4.6 calls to 1 put with a focus on March 80 and April 65 calls

Mar 6, 2025 09:37AM SpringWorks Therapeutics Inc. (SWTX) ticks higher on chatter

Feb 20, 2025 06:35AM Southwall Technologies, Inc. (SWTX) Misses Q4 EPS by 39c

Feb 12, 2025 11:52AM Spring Works Therapeutics (SWTX) PT Raised to $66 at TD Cowen Following Gomekli's Approval

Feb 11, 2025 05:32PM SpringWorks Therapeutics Inc. (SWTX) announces FDA approval of GOMELKI

Feb 11, 2025 03:45PM FDA approves SpringWorks' (SWTX) mirdametinib for adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas not amenable to complete resection

Feb 11, 2025 04:59AM Increasing unusual option volume: SWTX AIOT BTE NVT VNET YMM CENX

Feb 10, 2025 09:52AM Merck Kgaa In Advanced Discussions To Acquire Springworks Therapeutics (SWTX) , Sources Say - Reuters

Jan 13, 2025 06:34AM SpringWorks Therapeutics Inc. (SWTX) Reports Prelim Q4 Results, Provides Business Updates

Jan 8, 2025 07:08AM Spring Works Therapeutics (SWTX) PT Lowered to $78 at Guggenheim

Nov 30, 2024 10:00PM JPMorgan is out with its 2025 outlook for biotech stocks

Nov 20, 2024 06:16AM Evercore ISI Starts Spring Works Therapeutics (SWTX) at Outperform

Nov 19, 2024 11:00AM JPM just added these stocks to its Analyst Focus List - giving one 148% upside

Nov 13, 2024 06:52AM Spring Works Therapeutics (SWTX) PT Lowered to $74 at H.C. Wainwright

Nov 12, 2024 06:31AM Southwall Technologies, Inc. (SWTX) Tops Q3 EPS by 3c

Nov 7, 2024 06:30AM SpringWorks Therapeutics (SWTX) Reports Long-Term Efficacy and Safety Data from Phase 3 DeFi Trial of OGSIVEO

Sep 4, 2024 06:43AM Spring Works Therapeutics (SWTX) PT Raised to $68 at JPMorgan

Sep 3, 2024 04:58AM Goldman Sachs Reiterates Buy Rating on Spring Works Therapeutics (SWTX)

Aug 29, 2024 08:16AM H.C. Wainwright Reiterates Buy Rating on Spring Works Therapeutics (SWTX)

Aug 28, 2024 06:31AM SpringWorks Therapeutics Inc. (SWTX) Granted FDA Priority Review to NDA for Mirdametinib

Aug 8, 2024 06:37AM Spring Works Therapeutics (SWTX) PT Raised to $76 at H.C. Wainwright

Aug 7, 2024 06:33AM Southwall Technologies, Inc. (SWTX) Tops Q2 EPS by 58c

Jul 29, 2024 06:47AM SpringWorks Therapeutics Inc. (SWTX) Appoints Dr. Martin Mackay to its Board of Directors

Jul 2, 2024 02:30PM Barclays Reiterates Overweight Rating on Spring Works Therapeutics (SWTX)

Jul 1, 2024 06:31AM SpringWorks Therapeutics Inc. (SWTX) Completes Submission of NDA for Mirdametinib

Jun 27, 2024 12:33PM TD Cowen Reiterates Buy Rating on Spring Works Therapeutics (SWTX)